Archives
-
CTP Solution (100 mM) for IVT and RNA Workflows
2026-09-28
CTP Solution (100 mM) is a high-purity aqueous Cytidine-5'-triphosphate reagent for in vitro transcription, RNA amplification, and related enzymatic assays. Its defined concentration, near-neutral pH, contamination controls, and low-temperature storage guidance support reproducible substrate delivery, but the reagent does not itself encode, deliver, or validate therapeutic mRNA.
-
Imipramine Workflows for Autophagy and Apoptosis
2026-09-28
Build complementary glioma autophagy and leukemia apoptosis workflows with Imipramine, while keeping transporter potency distinct from cell-based effects. A fish-virus lipidomics study offers useful experimental-design lessons about autophagy and pathway controls—not evidence that Imipramine is antiviral or acts through ceramides.
-
EdU Imaging Kits (488) for HCC Proliferation Studies
2026-09-27
Pair a short EdU pulse with green-fluorescent click labeling to measure S-phase entry in hepatocellular carcinoma models—without the DNA-denaturation step commonly used for BrdU. The workflow offers a practical way to test proliferation phenotypes alongside HAUS1 perturbation while retaining nuclear morphology for microscopy or flow cytometry.
-
DiscoveryProbe Bioactive Compound Library Plus: Assay Logic
2026-09-26
The DiscoveryProbe Bioactive Compound Library Plus supports systematic chemical perturbation across diverse pathways. This article connects thermal-shift ligand screening to practical target-validation decisions, clarifying what a compound-library hit can—and cannot—show.
-
S-Adenosylhomocysteine in Neural Radiation Research
2026-09-25
Use SAH as a metabolic perturbation to test whether methylation potential modifies radiation-associated neural differentiation—not as a mechanism already established by radiation studies. This guide pairs a practical dose-screening workflow with pathway, phenotype, and troubleshooting controls for C17.2 cells and primary neural stem cells.
-
LTI6426 Sensitizes Myeloma to Low-Dose Panobinostat
2026-09-25
A preclinical study found that the protein disulfide isomerase inhibitor LTI6426 enhanced panobinostat activity in multiple myeloma models, including a proteasome inhibitor-resistant model. The combination also induced an endoplasmic-reticulum-stress-associated transcriptional program, offering candidate response markers and a rationale to investigate dose-sparing strategies without implying clinical validation.
-
TECPR1 Tubulation Repairs Lysosomes Under Energy Stress
2026-09-24
A 2026 study identifies TECPR1 as a mediator of lysosomal membrane repair during glucose starvation and chemically induced damage. By recruiting to PI4P-enriched membranes and working with KIF1A to generate tubules, TECPR1 helps remove damaged membrane components, supporting cellular lipid balance and liver resilience in a mouse model.
-
Partial BACE Inhibition Preserves Synaptic Transmission
2026-09-24
Satir and colleagues tested whether reducing amyloid-beta production with BACE inhibitors necessarily disrupts neuronal synaptic transmission. In cultured rat cortical neurons, modest inhibition that lowered secreted Aβ by less than 50% did not measurably reduce transmission, whereas stronger inhibition did—supporting dose-sensitive investigation rather than assuming that all BACE inhibition has the same functional effect.
-
EdU Imaging Kits (488) for CRC S-Phase Assays
2026-09-23
Connect colorectal cancer pathway experiments to a direct readout of DNA replication with sensitive, green-fluorescent EdU labeling. This workflow guide explains how to use EdU Imaging Kits (488) to compare CRC cell conditions while preserving morphology and planning around assay limits.
-
Adefovir: From HBV Assay to Renal Risk
2026-09-23
Adefovir (GS-0393) is more than a selective HBV polymerase inhibitor. This translational guide connects its antiviral mechanism, OAT1 transport behavior, assay design, and the laboratory clues that distinguish drug-associated phosphate wasting from inflammatory bone disease.
-
OMV-Displayed mRNA for Personalized Tumor Vaccines
2026-09-22
Li and colleagues developed engineered bacterial outer membrane vesicles that rapidly bind sequence-labelled mRNA and deliver it to dendritic cells. By combining the RNA-binding protein L7Ae with listeriolysin O, the platform supported antitumor responses, tumor regression, and durable immune memory in mouse models.
-
Capecitabine: A Rigorous Assay-Design Framework
2026-09-22
Capecitabine is examined here as a context-sensitive fluoropyrimidine prodrug rather than a simple viability reagent. Learn how matched gastric cancer assembloids, thymidine phosphorylase biology, and orthogonal readouts can improve preclinical oncology research.
-
MK-571 (L-660,711) Research Workflows
2026-09-21
MK-571 (L-660,711) supports two distinct experimental strategies: selective cysLT1 receptor blockade in airway inflammation models and MRP1-focused transporter studies in immune cells. This practical guide connects assay design, formulation, controls, reference-study insights, and troubleshooting for more interpretable leukotriene and drug-response experiments.
-
Trypsin Workflow Guide for Cell and Protein Assays
2026-09-21
Turn Trypsin into a controlled tool for cell dissociation, protein digestion, and mechanism-focused assays rather than a one-size-fits-all reagent. This guide connects practical handling of BA5744 with the SMAD3–miRNA-140–ADAMTS-5 osteoarthritis model and carefully bounded applications in wound healing, inflammation, and viral fusion research.
-
7-dehydro Cholesterol: A Translation Framework
2026-09-20
7-dehydro Cholesterol is more than a sterol intermediate: it is a decision point linking cholesterol biosynthesis research, UVB photobiology, and disease-model biology. This article explains how to design assays that distinguish chemical substrate effects from DHCR7 genetic perturbation, using new grass carp antiviral evidence as a translational case study.